Editorial : Vaccination strategies against ruminant infectious diseases
Ruminant infectious diseases cause economic impact through losses in animal production and human health. Most of the commercially available veterinary vaccines are live attenuated or inactivated which induce different degrees of efficacy, i.e., decrease in clinical symptoms, pathogen dissemination,...
| Autores principales: | , , |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Inglés |
| Publicado: |
Frontiers Media
2023
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/15124 https://www.frontiersin.org/articles/10.3389/fvets.2023.1213269/full https://doi.org/10.3389/fvets.2023.1213269 |
Ejemplares similares: Editorial : Vaccination strategies against ruminant infectious diseases
- Molecular characterization of infectious bursal disease virus (IBDV) isolated in Argentina indicates a regional lineage
- Plant-based vaccine candidate against Infectious bursal disease: an alternative to inactivated vaccines for breeder hens
- Bovine colostral cells—the often forgotten component of colostrum
- Immune response in calves vaccinated with type three secretion system antigens and shiga toxin 2B subunit of Escherichia coli O157:H7
- Characterization of a Nanovaccine Platform Based on an α1,2- Mannobiose Derivative Shows Species-non-specific Targeting to Human, Bovine, Mouse, and Teleost Fish Dendritic Cells
- Live attenuated Mycobacterium bovis strains combined with the encapsulated H65 antigen as a vaccine strategy against bovine tuberculosis in a mouse model